First Amendment to Jade Biosciences, Inc. 2024 Equity Incentive Plan

Contract Categories: Human Resources › Bonus & Incentive Agreements
Summary

Jade Biosciences, Inc. has amended its 2024 Equity Incentive Plan, effective November 20, 2024. The amendment increases the number of shares of common stock available for awards under the plan to 12,783,695, all of which may be granted as Incentive Stock Options. All other terms of the plan remain unchanged. The amendment is governed by Delaware law.

Read More Arrow
EX-10.7 11 d847557dex107.htm EX-10.7 EX-10.7

Exhibit 10.7

FIRST AMENDMENT TO THE

JADE BIOSCIENCES, INC.

2024 EQUITY INCENTIVE PLAN

WHEREAS, Jade Biosciences, Inc., a Delaware corporation (the “Company”), maintains the Jade Biosciences, Inc. 2024 Equity Incentive Plan, as amended and restated (the “Plan”); and

WHEREAS, pursuant to Section 10(d) of the Plan, the Board may amend the Plan at any time.

NOW, THEREFORE, pursuant to its authority under Section 10(d) of the Plan, the Board hereby amends the Plan as follows, effective as of November 20, 2024 (the “Amendment Effective Date”):

 

1.

The first sentence of Section 4(a) of the Plan is hereby amended and restated in its entirety to read as follows:

“Subject to adjustment under Section 8 hereof, Awards may be made under the Plan covering up to 12,783,695 shares of common stock of the Company (the “Common Stock”), all of which may be granted as Incentive Stock Options (as defined below).”

 

2.

This amendment shall be governed by and interpreted in accordance with the laws of the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than such state.

 

3.

All capitalized terms used but not otherwise defined herein shall have the meaning assigned to them in the Plan. Except as expressly amended hereby, the Plan shall remain in full force and effect in accordance with its terms.

[Signature Page Follows]

IN WITNESS WHEREOF, the undersigned has executed this First Amendment to the Jade Biosciences, Inc. 2024 Equity Incentive Plan, as amended and restated, effective as of the Amendment Effective Date.

 

JADE BIOSCIENCES, INC.
By:  

/s/ Jonathan Quick

Name:   Jonathan Quick
Title:   SVP, Finance

SIGNATURE PAGE TO

FIRST AMENDMENT TO THE

JADE BIOSCIENCES, INC.

2024 EQUITY INCENTIVE PLAN